EUVIMEDEUVIMED entdecken
Open Access

Lipophilic statins inhibit YAP coactivator transcriptional activity in HCC cells through Rho-mediated modulation of actin cytoskeleton

Jihane N Benhammou iD, Bo Qiao, Arthur Ko, James Sinnett-Smith iD, Joseph R Pisegna, Enrique Rozengurt iD

American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.09.2023 · 325 (3) · G239-G250

DOI: 10.1152/ajpgi.00089.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.09.2023. Verfasst von Jihane N Benhammou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Vatche and Tamar Manoukian Division of Digestive Diseases, University of California, Los Angeles, California, United States. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Liver Neoplasms, YAP-Signaling Proteins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, HHS | NIH | National Center for Advancing Translational Sciences (NCATS), Foundation for the National Institutes of Health (FNIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Statins are widely used for the treatment of cardiovascular diseases. Recently, their use has been associated with a decrease in the incidence of hepatocellular carcinoma (HCC); however, their mechanism(s) has remained elusive. In this study, we delineate the mechanism by which statins affect the Yes-associated protein (YAP), which has emerged as a key oncogenic pathway in HCC. We investigate each step of the mevalonate pathway and demonstrate that statins regulate YAP via Rho GTPases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularHydroxymethylglutaryl-CoA Reductase InhibitorsLiver NeoplasmsYAP-Signaling ProteinsHumansActin CytoskeletonAdaptor Proteins, Signal TransducingMevalonic Acidrho GTP-Binding Proteins

Stichwörter der Autor:innen

YAPchemopreventionhepatocellular carcinomastatin

Substanzen

Adaptor Proteins, Signal TransducingHydroxymethylglutaryl-CoA Reductase InhibitorsMevalonic Acidrho GTP-Binding ProteinsYAP-Signaling ProteinsYAP1 protein, human

Autor:innen und Institutionen

  • Vatche and Tamar Manoukian Division of Digestive Diseases, University of California, Los Angeles, California, United States.
  • Division of Gastroenterology, Hepatology and Parental Nutrition, Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States.
  • Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California, United States.
  • Center for Genetic Medicine Research, Childrens National Research Institute, Washington, District of Columbia, United States.

ORCID-Profile: Jihane N Benhammou, James Sinnett-Smith, Enrique Rozengurt

Förderung

  • NCI NIH HHS
  • HHS | NIH | National Center for Advancing Translational Sciences (NCATS)
  • Foundation for the National Institutes of Health (FNIH)
  • BLRD VA
  • NCATS NIH HHS
  • NIAID NIH HHS
  • U.S. Department of Veterans Affairs

Zitieren

APA

Benhammou, J. N., Qiao, B., Ko, A., Sinnett-Smith, J., Pisegna, J. R., & Rozengurt, E. (2023). Lipophilic statins inhibit YAP coactivator transcriptional activity in HCC cells through Rho-mediated modulation of actin cytoskeleton. American Journal of Physiology-Gastrointestinal and Liver Physiology, 325(3), G239-G250. https://doi.org/10.1152/ajpgi.00089.2023

Vancouver

Benhammou JN, Qiao B, Ko A, Sinnett-Smith J, Pisegna JR, Rozengurt E. Lipophilic statins inhibit YAP coactivator transcriptional activity in HCC cells through Rho-mediated modulation of actin cytoskeleton. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2023;325(3):G239-G250. doi:10.1152/ajpgi.00089.2023

BibTeX
@article{Benhammou2023,
  author = {Benhammou, Jihane N and Qiao, Bo and Ko, Arthur and Sinnett-Smith, James and Pisegna, Joseph R and Rozengurt, Enrique},
  title = {Lipophilic statins inhibit YAP coactivator transcriptional activity in HCC cells through Rho-mediated modulation of actin cytoskeleton},
  journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
  year = {2023},
  volume = {325},
  number = {3},
  pages = {G239--G250},
  doi = {10.1152/ajpgi.00089.2023}
}
Kostenlos starten →